Hyong Kim Sells 16,506 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 16,506 shares of the stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $21.35, for a total value of $352,403.10. Following the completion of the sale, the insider owned 333,133 shares of the company’s stock, valued at approximately $7,112,389.55. This trade represents a 4.72% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Hyong Kim also recently made the following trade(s):

• On Monday, December 29th, Hyong Kim sold 12,694 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total value of $237,885.56.
• On Thursday, October 9th, Hyong Kim sold 51,379 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.57, for a total transaction of $902,729.03.
• On Wednesday, October 8th, Hyong Kim sold 33,655 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.29, for a total transaction of $581,894.95.

Alignment Healthcare Price Performance

Shares of ALHC stock opened at $20.93 on Thursday. The firm has a fifty day simple moving average of $18.55 and a 200-day simple moving average of $16.46. The company has a market capitalization of $4.19 billion, a PE ratio of -174.42, a price-to-earnings-growth ratio of 6.12 and a beta of 1.16. Alignment Healthcare, Inc. has a twelve month low of $11.48 and a twelve month high of $21.65. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Thursday, October 30th. The company reported $0.02 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The firm had revenue of $993.70 million for the quarter, compared to analyst estimates of $980.90 million. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The firm’s revenue was up 43.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.14) EPS. Equities research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ALHC has been the subject of a number of recent analyst reports. KeyCorp reissued an “overweight” rating on shares of Alignment Healthcare in a research report on Monday, November 24th. The Goldman Sachs Group reissued a “buy” rating and set a $22.00 price objective on shares of Alignment Healthcare in a report on Monday, November 3rd. JPMorgan Chase & Co. boosted their target price on shares of Alignment Healthcare from $20.00 to $23.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 28th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $21.25.

Alignment Healthcare News Roundup

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Recent quarterly results showed revenue strength and an EPS beat (Qtr revenue ≈ $993.7M, +43.5% YoY; EPS $0.02 vs. consensus -$0.01), which supports growth expectations and helps explain upside interest from investors. Read More.
• Neutral Sentiment: Analyst coverage is active — some firms have raised price targets (consensus ~$21.25) while others remain neutral; Benzinga’s analyst roundup could amplify moves if any major upgrades or target changes are published. Read More.
• Negative Sentiment: Large insider sales were disclosed this week, including significant dispositions by President Dawn Maroney (100,000 shares sold ~Jan 2 and a separate filing showing 228,152 shares sold) and other executives (Christopher Joyce, Hyong Kim). Investors often interpret material executive selling near highs as profit-taking or reduced insider conviction, which can pressure the stock. Read More. • Read More.
• Negative Sentiment: A recent valuation-focused piece raises the question of whether current valuations already price in expected growth, signalling potential overpaying risk for new buyers if execution slows or multiples compress. That stokes caution even with solid top-line growth. Read More.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ALHC. Strs Ohio acquired a new position in shares of Alignment Healthcare during the first quarter worth approximately $600,000. Inspire Investing LLC bought a new stake in Alignment Healthcare during the 3rd quarter valued at $1,129,000. Ameritas Investment Partners Inc. boosted its position in Alignment Healthcare by 32.9% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock worth $182,000 after acquiring an additional 3,225 shares during the period. Schroder Investment Management Group grew its stake in shares of Alignment Healthcare by 28.7% in the second quarter. Schroder Investment Management Group now owns 248,163 shares of the company’s stock worth $3,437,000 after purchasing an additional 55,314 shares in the last quarter. Finally, Jump Financial LLC grew its stake in shares of Alignment Healthcare by 173.8% in the second quarter. Jump Financial LLC now owns 1,056,600 shares of the company’s stock worth $14,792,000 after purchasing an additional 670,750 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.